पदोन्नति कार्यक्रम Intensity Therapeutics, Inc.
उन्नत शेड्यूल
सरल ग्राफ
कंपनी के बारे में Intensity Therapeutics, Inc.
Intensity Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of cancer drugs to treat solid tumors. Its lead product candidate includes INT230-6, a clinical trial for the treatment of refractory solid tumors and pancreatic, colon, bile duct, squamous cell carcinoma, sarcoma, breast, and liver cancers. The company was incorporated in 2012 and is headquartered in Westport, Connecticut.IPO date | 2023-06-30 |
---|---|
ISIN | US45828J1034 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Сайт | https://intensitytherapeutics.com |
Цена ао | 2.04 |
प्रति दिन मूल्य परिवर्तन: | 0% (1.929) |
---|---|
प्रति सप्ताह मूल्य परिवर्तन: | -3.55% (2) |
प्रति माह मूल्य परिवर्तन: | -12.32% (2.2) |
3 महीने में कीमत में बदलाव: | -2.08% (1.97) |
छह महीने में कीमत में बदलाव: | -49.5% (3.82) |
प्रति वर्ष मूल्य परिवर्तन: | -62.9% (5.2) |
वर्ष की शुरुआत से मूल्य परिवर्तन: | -2.08% (1.97) |
|
बहुत मूल्यवान समझना
|
क्षमता
|
|||||||||||||||||||||||||||||||||||||
लाभांश
|
कर्तव्य
|
विकास का आवेग
|
संस्थानों | आयतन | शेयर करना, % |
---|---|---|
HOHIMER WEALTH MANAGEMENT, LLC | 186464 | 1.36 |
Sigma Planning Corp | 48144 | 0.35 |
Millennium Management LLC | 24822 | 0.18 |
Geode Capital Management, LLC | 23070 | 0.17 |
Blackrock Inc. | 10239 | 0.07 |
Wells Fargo & Company | 2480 | 0.02 |
Osaic Holdings Inc | 2000 | 0.01 |
Tower Research Capital LLC (TRC) | 1027 | 0.01 |
Glassman Wealth Services | 200 | 0 |
JP Morgan Chase & Company | 1 | 0 |
ETF | शेयर करना, % | वर्ष के लिए लाभप्रदता, % | लाभांश, % |
---|---|---|---|
iShares Micro-Cap ETF | 0.00866 | 17.09 | 1.54048 |
0.01 | 17.09 | 1.54 |
पर्यवेक्षक | नौकरी का शीर्षक | भुगतान | जन्म का साल |
---|---|---|---|
Mr. Lewis H. Bender M.A., M.B.A., M.S. | Founder, President, CEO & Chairman of the Board | 1.1M | 1959 (66 साल) |
Mr. John Wesolowski CPA, M.B.A. | Principal Accounting Officer & Controller | 272.37k | 1960 (65 साल) |
Mr. James M. Ahlers | Executive Vice President of Corporate Finance | 75.09k | 1964 (61 वर्ष) |
Mr. Brian Schwartz M.D. | Executive Vice President of Clinical Development | N/A | |
Mr. Joseph Talamo CPA, M.B.A. | Chief Financial Officer | N/A | 1969 (56 साल) |
पता: United States, Westport. CT, 61 Wilton Road - Google मानचित्र में खोलें, यांडेक्स मानचित्र खोलें
वेबसाइट: https://intensitytherapeutics.com
वेबसाइट: https://intensitytherapeutics.com